| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kalvista Pharmaceuticals, Inc. (KALV) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. KALV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 462.6K | $12.49M | - | |
| Other | 223.5K | $6.03M | - | |
| Other | 142.5K | $3.85M | - | |
| Other | 100.0K | $2.70M | - | |
| Other | 51.4K | $1.39M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2022 | Audhya Paul K. | Chief Medical Officer | Sale+OE | 722 | $5.44 | $3,927.68 | -10.8% | +49.7% | +59.5% | |
| Sep 2, 2022 | Crockett Thomas Andrew72 | CEO | Sell | 1,320 | $17.01 | $22,457.69 | -1.2% | -66.9% | -34.0% | |
| Aug 17, 2022 | Audhya Paul K. | Chief Medical Officer | Sale+OE | 725 | $14.96 | $10,847.09 | -30.0% | -65.7% | -28.1% | |
| Aug 17, 2022 | Feener Edward P.72 | Chief Scientific Officer | Sale+OE | 532 | $14.96 | $7,959.73 | -0.9% | -65.7% | -28.1% | |
| Aug 17, 2022 | Yea Christopher53 | Chief Development Officer | Sale+OE | 1,145 | $14.96 | $17,130.00 | -3.3% | -65.7% | -28.1% | |
| Aug 17, 2022 | Palleiko Benjamin L46 | CFO, Cbo &Secretary | Sale+OE | 725 | $14.96 | $10,846.58 | -1.1% | -65.7% | -28.1% | |
| Aug 17, 2022 | Crockett Thomas Andrew72 | CEO | Sale+OE | 1,797 | $14.96 | $26,890.49 | -1.6% | -65.7% | -28.1% | |
| Mar 9, 2022 | Crockett Thomas Andrew72 | CEO | Sell | 10,000 | $17.07 | $170,693.00 | -8.0% | -47.8% | -56.7% | |
| Nov 1, 2021 | Feener Edward P.72 | Chief Scientific Officer | Sell | 6,000 | $18.07 | $108,423.60 | -72.9% | -30.8% | -72.1% | |
| Nov 1, 2021 | Yea Christopher53 | Chief Development Officer | Sell | 5,000 | $18.07 | $90,328.00 | -13.2% | -30.8% | -72.1% |